Literature DB >> 32368517

Taking tuberculosis preventive therapy implementation to national scale: the Nigerian PEPFAR Program experience.

B Odume1, S C Meribe2, T Odusote3, M Ifunanya1, H Debem1, I Amazue-Ezeuko2,4, O Ogbanufe1, Y Adamu2, D Onotu1.   

Abstract

BACKGROUND: Tuberculosis (TB) preventive therapy (TPT), including isoniazid preventive therapy (IPT), has been implemented within the Nigerian human immunodeficiency virus (HIV) programme since 2014. However, drug procurement and logistic support has remained the responsibility of the National Tuberculosis and Leprosy Control Programme. The US President's Emergency Plan for AIDS Relief-Nigeria (PEPFAR Nigeria) reviewed the key bottlenecks to TPT implementation in 2016.
METHOD: The logistics of delivery of isoniazid (INH) were integrated with the antiretroviral (ARV) logistics management and information system (LMIS). Drug order and requisition forms at the facility level were revised to include INH, along with training on appropriate quantification and requisition of INH with ARVs. Support was provided for last mile delivery of INH directly to every implementing site, alongside ARV. REULTS: We observed an increasing trend in TPT uptake between the pre-and-post intervention periods: 6% in fiscal year (FY) 2015, 7% in FY2016 and 12% in FY2017. Overall, the logistical changes in the LMIS to include INH in 2016 led to a 69% increase in TPT by the end of FY2017; this was statistically significant.
CONCLUSION: Addressing logistical challenges to TPT implementation will ensure that the TB and HIV programmes can tackle the increasing burden of TB infection in people living with HIV. We recommended that the provider-to-client stage of TPT implementation be driven by the HIV programme and that cross-communication between the two programmes be improved.
© 2020 The Union.

Entities:  

Keywords:  TB preventive therapy; human immunodeficiency virus; isoniazid preventive therapy; people living with HIV; tuberculosis

Year:  2020        PMID: 32368517      PMCID: PMC7181361          DOI: 10.5588/pha.19.0033

Source DB:  PubMed          Journal:  Public Health Action        ISSN: 2220-8372


  3 in total

1.  Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial.

Authors:  Anani Badje; Raoul Moh; Delphine Gabillard; Calixte Guéhi; Mathieu Kabran; Jean-Baptiste Ntakpé; Jérôme Le Carrou; Gérard M Kouame; Eric Ouattara; Eugène Messou; Amani Anzian; Albert Minga; Joachim Gnokoro; Patrice Gouesse; Arlette Emieme; Thomas-d'Aquin Toni; Cyprien Rabe; Baba Sidibé; Gustave Nzunetu; Lambert Dohoun; Abo Yao; Synali Kamagate; Solange Amon; Amadou-Barenson Kouame; Aboli Koua; Emmanuel Kouamé; Marcelle Daligou; Denise Hawerlander; Simplice Ackoundzé; Serge Koule; Jonas Séri; Alex Ani; Fassery Dembélé; Fatoumata Koné; Mykayila Oyebi; Nathalie Mbakop; Oyewole Makaila; Carolle Babatunde; Nathaniel Babatunde; Gisèle Bleoué; Mireille Tchoutedjem; Alain-Claude Kouadio; Ghislaine Sena; Sahinou-Yediga Yededji; Sophie Karcher; Christine Rouzioux; Abo Kouame; Rodrigue Assi; Alima Bakayoko; Serge K Domoua; Nina Deschamps; Kakou Aka; Thérèse N'Dri-Yoman; Roger Salamon; Valérie Journot; Hughes Ahibo; Timothée Ouassa; Hervé Menan; André Inwoley; Christine Danel; Serge P Eholié; Xavier Anglaret
Journal:  Lancet Glob Health       Date:  2017-11       Impact factor: 26.763

2.  Barriers in the implementation of isoniazid preventive therapy for people living with HIV in Northern Ethiopia: a mixed quantitative and qualitative study.

Authors:  Gebrehiwot Teklay; Tsigemariam Teklu; Befikadu Legesse; Kiros Tedla; Eveline Klinkenberg
Journal:  BMC Public Health       Date:  2016-08-19       Impact factor: 3.295

Review 3.  Prevalence of tuberculosis in post-mortem studies of HIV-infected adults and children in resource-limited settings: a systematic review and meta-analysis.

Authors:  Rishi K Gupta; Sebastian B Lucas; Katherine L Fielding; Stephen D Lawn
Journal:  AIDS       Date:  2015-09-24       Impact factor: 4.177

  3 in total
  4 in total

1.  Sustaining tuberculosis preventive therapy scale-up through direct supportive supervision.

Authors:  S C Meribe; Y Adamu; E Adebayo-Abikoye; I Lawal; I Amazue-Ezeuko; N Okeji; I Okoye; P Agaba; R Nelson; E Lee; L Chittenden
Journal:  Public Health Action       Date:  2020-06-21

2.  Implementation of tuberculosis preventive treatment among people living with HIV, South Sudan.

Authors:  Andrew T Boyd; Dennis Kenyi Lodiongo; John Mondi Benson; Shambel Aragaw; Margaret Semira Pasquale; Habtamu Ayalneh; Robert Olemukan; Isaac Avaku; Nicholas Baabe; Victoria Achut; Helen Chun; Sudhir Bunga
Journal:  Bull World Health Organ       Date:  2020-10-28       Impact factor: 9.408

3.  Brief Report: Programmatic Scale-up of Tuberculosis Preventive Treatment Among People Living With HIV Through Targeted Technical Assistance to High-Volume Antiretroviral Treatment Sites-Nigeria, 2018-2019.

Authors:  Andrew T Boyd; Bethrand Odume; Kassim Sidibe; Dennis Onotu; Obinna Ogbanufe; Ifunanya Mgbakor; Mahesh Swaminathan
Journal:  J Acquir Immune Defic Syndr       Date:  2020-12-01       Impact factor: 3.771

4.  Attaining 95-95-95 through Implementation Science: 15 Years of Insights and Best Practices from the Walter Reed Army Institute of Research's Implementation of the U.S. President's Emergency Plan for AIDS Relief.

Authors:  Elizabeth H Lee; Kavitha Ganesan; Samoel A Khamadi; Stanley C Meribe; Dorothy Njeru; Yakubu Adamu; Fred Magala; Trevor A Crowell; Eniko Akom; Patricia Agaba; Priyanka Desai; Tiffany Hamm; Deydre Teyhen; Julie A Ake; Christina S Polyak; Douglas Shaffer; Fredrick Sawe; Patrick W Hickey
Journal:  Am J Trop Med Hyg       Date:  2021-01       Impact factor: 3.707

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.